CLINUVEL preparing upgrade of ADR program to Level II, Nasdaq uplist 2025 Announcements.Corporate.Financial.News 22.08.2025
19th Bioshares Biotech Summit Presentation 2025 Announcements . Corporate . Financial . News . Presentation 07.08.2025
Presentation to the BTIG Biotechnology Conference 2025 Announcements . Corporate . Financial . News . Presentation 30.07.2025
German Non-deal Roadshow Presentation 2025 Announcements . Corporate . Financial . News . Presentation 24.06.2025
Pilot study confirms adjunct NB-UVB needed to activate repigmentation in vitiligo 2025 Announcements . Clinical . News 18.06.2025
SCENESSE® successfully administered to paediatric EPP patient 2025 Announcements . Corporate . News . Newsletter 13.06.2025